MedPath

JOHNSON & JOHNSON PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

13

HSA:13

Drug Approvals

NICORETTE QUICKMIST MOUTHSPRAY 1MG/SPRAY

Approval Date
Aug 8, 2022
HSA

TYLENOL FILM COATED TABLETS 500MG

Approval Date
Jun 6, 2020
HSA

REGAINE Extra Strength (5%)

Approval Date
Jun 19, 1995
HSA

IMODIUM CAPSULE 2 mg

Approval Date
May 8, 1991
HSA

REGAINE Regular Strength (2%)

Approval Date
May 3, 1990
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)

Not Applicable
Completed
Conditions
Adult Skin Healthy Signs
First Posted Date
2017-08-29
Last Posted Date
2018-04-11
Lead Sponsor
Johnson & Johnson Pte Ltd
Target Recruit Count
122
Registration Number
NCT03264677
Locations
🇨🇳

Shanghai Skin Disease Hospital, Shanghai, Shanghai, China

News

No news found
© Copyright 2025. All Rights Reserved by MedPath